Skip to content
BiologicalX

Comparison

N-Acetyl Cysteine vs Vitamin D3 + K2

Side-by-side of N-Acetyl Cysteine and Vitamin D3 + K2. Every row below is pulled from the compound schema and will update as our data grows. For deeper reads, follow through to each compound page.

Effects at a glance

N-Acetyl Cysteine

  • Replenishes intracellular glutathione by supplying cysteine, the rate-limiting amino acid for synthesis
  • First-line antidote for acetaminophen toxicity, restoring hepatic glutathione before fulminant injury occurs
  • Reduces sputum viscosity in chronic bronchitis and COPD at 600 to 1200 mg/day over months
  • Modest symptom reductions in OCD and trichotillomania at 1200 to 2400 mg/day across small RCTs
  • Mixed evidence for psychiatric adjunct use in bipolar depression and schizophrenia negative symptoms
  • Inhaled forms can trigger bronchospasm in active asthma; oral use is the standard biohacker route

Vitamin D3 + K2

  • Reduces non-vertebral fractures 10-20% in older adults at 800 IU/day or above when combined with calcium
  • VITAL trial showed neutral results on primary CV and cancer endpoints at 2000 IU/day over 5 years
  • Vitamin D supplementation reduces respiratory infection incidence ~10-20% in deficient populations
  • K2 MK-7 has 72-hour plasma half-life vs 1-2 hours for MK-4; once-daily dosing is sufficient
  • Synergy hypothesis is largely preclinical; dedicated combination RCTs are limited
  • Daily dosing outperforms bolus dosing for immune and infection outcomes

Side-by-side

Attribute N-Acetyl Cysteine Vitamin D3 + K2
Category supplement supplement
Also known as NAC cholecalciferol + menaquinone, D3/K2, vitamin D3 with MK-7
Half-life (hr) 5.6 360
Typical dose (mg) 1200 0.05
Dosing frequency 1 to 3 times daily, split dosing preferred daily with a fat-containing meal
Routes oral, iv oral
Onset (hr) 1 24
Peak (hr) 2 168
Molecular weight 163.19 384.64
Molecular formula C5H9NO3S C27H44O (D3); C46H64O2 (MK-7)
Mechanism Deacetylated to cysteine, the rate-limiting precursor for glutathione synthesis; also directly scavenges reactive oxygen species and modulates glutamate signaling. D3 converts to calcidiol then calcitriol, activating the vitamin D receptor (VDR) to increase intestinal calcium absorption and modulate immune and bone gene transcription. K2 carboxylates osteocalcin and matrix Gla protein, directing calcium toward bone and inhibiting vascular calcification.
Legal status OTC in most jurisdictions; restricted periods in US history (FDA reclassified 2022) Dietary supplement (global)
WADA status allowed allowed
DEA / Rx OTC supplement (US, post-2022); Rx indications also exist (acetaminophen overdose, mucolytic) Not scheduled
Pregnancy Used clinically in pregnancy for specific indications; consult clinician Recommended at standard doses for fetal bone development; consult clinician at higher doses
CAS 616-91-1 67-97-0
PubChem CID 12035 5280795
Wikidata Q413299 Q139347

Safety profile

N-Acetyl Cysteine

Common side effects

  • sulfur-like taste or odor
  • nausea
  • flatulence
  • diarrhea

Contraindications

  • active asthma attack (inhaled form can trigger bronchospasm)
  • known NAC hypersensitivity

Interactions

  • nitroglycerin: potentiates vasodilation, risk of hypotension and headache(moderate)
  • activated charcoal: reduces NAC absorption when used for acetaminophen overdose(moderate)
  • anticoagulants: theoretical additive antiplatelet effect at high doses(minor)

Vitamin D3 + K2

Common side effects

  • GI upset at high doses
  • headache (rare)
  • hypercalcemia (only at sustained very high D3 doses)

Contraindications

  • hypercalcemia
  • sarcoidosis
  • active hyperparathyroidism
  • warfarin therapy (K2 component requires stable intake)

Interactions

  • warfarin: K2 component can affect anticoagulation; maintain stable intake and inform anticoagulation clinic(moderate)
  • thiazide diuretics: additive calcium retention; hypercalcemia risk with high-dose D3(moderate)
  • digoxin and calcium channel blockers: additive effects from D3-induced hypercalcemia(moderate)
  • glucocorticoids: reduced vitamin D efficacy and bone effects(moderate)
  • cholestyramine and orlistat: bind fat-soluble vitamins; separate dosing by 2 to 4 hours(moderate)

Which Should You Take?

Vitamin D3 + K2 comes out ahead for most readers on the criteria we weight: 3 catalogued goals, OTC dietary supplement, oral dosing, with a Tier-A outcome catalogued. N-Acetyl Cysteine is the right call when one of the conditionals below applies.

Edge case: Half-lives differ materially (N-Acetyl Cysteine ~5.6 hr vs Vitamin D3 + K2 ~360 hr). Vitamin D3 + K2 reaches steady state faster; N-Acetyl Cysteine is easier to dial in if tolerability is uncertain.

Default choice: Vitamin D3 + K2. Lower friction to source, a Tier-A evidence outcome catalogued, and broader goal coverage. Reach for N-Acetyl Cysteine only if your priority sits squarely in the goals it owns above.

This verdict is generated from each compound's schema (goals, legal status, evidence outcomes, dosing route). It updates automatically as our compound data evolves; the deeper read sits on each individual compound page.

Common questions

What is the difference between N-Acetyl Cysteine and Vitamin D3 + K2?

N-Acetyl Cysteine and Vitamin D3 + K2 differ in category (supplement vs supplement), mechanism, and typical dosing. See the side-by-side table for full details.

Which has a longer half-life, N-Acetyl Cysteine or Vitamin D3 + K2?

N-Acetyl Cysteine half-life is 5.6 hours; Vitamin D3 + K2 half-life is 360 hours.

Can you stack N-Acetyl Cysteine with Vitamin D3 + K2?

Stack compatibility depends on mechanism overlap, legal status, and individual response. Check each compound page for specific interactions and contraindications before combining.

Go deeper